Literature DB >> 33250148

Autoencoded DNA methylation data to predict breast cancer recurrence: Machine learning models and gene-weight significance.

Laura Macías-García1, María Martínez-Ballesteros2, José María Luna-Romera3, José M García-Heredia4, Jorge García-Gutiérrez5, José C Riquelme-Santos6.   

Abstract

Breast cancer is the most frequent cancer in women and the second most frequent overall after lung cancer. Although the 5-year survival rate of breast cancer is relatively high, recurrence is also common which often involves metastasis with its consequent threat for patients. DNA methylation-derived databases have become an interesting primary source for supervised knowledge extraction regarding breast cancer. Unfortunately, the study of DNA methylation involves the processing of hundreds of thousands of features for every patient. DNA methylation is featured by High Dimension Low Sample Size which has shown well-known issues regarding feature selection and generation. Autoencoders (AEs) appear as a specific technique for conducting nonlinear feature fusion. Our main objective in this work is to design a procedure to summarize DNA methylation by taking advantage of AEs. Our proposal is able to generate new features from the values of CpG sites of patients with and without recurrence. Then, a limited set of relevant genes to characterize breast cancer recurrence is proposed by the application of survival analysis and a pondered ranking of genes according to the distribution of their CpG sites. To test our proposal we have selected a dataset from The Cancer Genome Atlas data portal and an AE with a single-hidden layer. The literature and enrichment analysis (based on genomic context and functional annotation) conducted regarding the genes obtained with our experiment confirmed that all of these genes were related to breast cancer recurrence.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoencoder; Breast cancer; DNA methylation; Feature generation; Machine learning

Year:  2020        PMID: 33250148     DOI: 10.1016/j.artmed.2020.101976

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  5 in total

1.  A Deep Survival EWAS approach estimating risk profile based on pre-diagnostic DNA methylation: An application to breast cancer time to diagnosis.

Authors:  Michela Carlotta Massi; Lorenzo Dominoni; Francesca Ieva; Giovanni Fiorito
Journal:  PLoS Comput Biol       Date:  2022-09-26       Impact factor: 4.779

2.  Neural Network Aided Detection of Huntington Disease.

Authors:  Gerardo Alfonso Perez; Javier Caballero Villarraso
Journal:  J Clin Med       Date:  2022-04-10       Impact factor: 4.964

Review 3.  Integrated Analysis of Whole Genome and Epigenome Data Using Machine Learning Technology: Toward the Establishment of Precision Oncology.

Authors:  Ken Asada; Syuzo Kaneko; Ken Takasawa; Hidenori Machino; Satoshi Takahashi; Norio Shinkai; Ryo Shimoyama; Masaaki Komatsu; Ryuji Hamamoto
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

4.  Artificial intelligence (AI) in breast cancer care - Leveraging multidisciplinary skills to improve care.

Authors:  Maria Joao Cardoso; Nehmat Houssami; Giuseppe Pozzi; Brigitte Séroussi
Journal:  Breast       Date:  2020-12-09       Impact factor: 4.380

5.  Automated Breast Cancer Detection Models Based on Transfer Learning.

Authors:  Madallah Alruwaili; Walaa Gouda
Journal:  Sensors (Basel)       Date:  2022-01-24       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.